The 3rd International Congress of Transfusion Medicine

The 3rd International Congress of Transfusion Medicine held in Tehran during 15-17 December 2015, focusing on the theme of evidence-based use of blood and blood components. More than 600 participants from 16 different countries attended the event.

After holding two successful international congresses of transfusion medicine in 2007 and 2011,The 3rd Congress was jointly organized by High Institute for Research and Education in Transfusion Medicine, Iranian Blood Transfusion Organization, International Society of Blood Transfusion (ISBT), Asian Association of Transfusion Medicine (AATM), French Blood Service , European School of Transfusion Medicine (ESTM) and WHO Collaborating Center for Research and Training on Blood Safety.

The Congress was opened by Dr. Ali Akbar Pourfathollah, Managing Director of Iranian Blood Transfusion Organization (IBTO) and the President of Congress. After welcoming all participants  and thanking the Congress organizers, Dr. Pourfathollah remarked that 41 years since the establishment, IBTO has achieved considerable improvements in different fields such as reaching the rate of 27 blood donation in 1000 population and 52% regular blood donation.

During the opening ceremony, Dr. Fereydoon Ala, founder of IBTO was honored for his lifelong excellence and perfection.

The congress covered a wide range of topics containing from recruitment of voluntary blood donors, blood safety and quality control, thromboses & homeostasis, blood transfusion in pediatric and obstetrics, blood transfusion in disasters, cell therapy, plasma-derived medicines, hemovigilance to patient blood management.

In the closing ceremony which coincided with “Investigator Day”, all top researchers of IBTO in 2015 were appreciated and the memorial plaque of the 3rd Congress of Transfusion Medicine were presented to all international speakers and participants.

Darmanyab Salamat Pouya (DYSP) was platinum sponsor of this congress and introduced new products of Fresenius Kabi Transfusion Technology Company (including C.A.T.S and Aurora plasmapheresis).  In this congress DYSP hosted senior managers of the IBTO and all of the provinces’ local general managers of IBTO in its booth.